Overview

A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the efficacy and safety of obexelimab in participants with relapsing multiple sclerosis
Phase:
PHASE2
Details
Lead Sponsor:
Zenas BioPharma (USA), LLC